Cargando…

p63 inhibits CD44(+)/CD24(−) cell proliferation and chemoresistance in papillary thyroid carcinoma cells

Thyroid cancer typically has a good prognosis; however, the risks of recurrence and chemoresistance associated with thyroid cancer remain a cause for concern. Papillary thyroid carcinoma (PTC) comprises 80% of all cases of thyroid carcinoma. A previous study reported that cluster of differentiation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jing-Jing, Xu, Hong-Shun, Wu, Gang, Ma, Zhen-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704253/ https://www.ncbi.nlm.nih.gov/pubmed/29201169 http://dx.doi.org/10.3892/etm.2017.5137

Ejemplares similares

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid
por: El Demellawy, Dina, et al.
Publicado: (2008)

Dynamic regulation of CD24 and the invasive, CD44(pos)CD24(neg )phenotype in breast cancer cell lines
por: Meyer, Matthew J, et al.
Publicado: (2009)

Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
por: Jaggupilli, Appalaraju, et al.
Publicado: (2012)

Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms
por: Magalhães, Geórgia Modé, et al.
Publicado: (2013)

Identification of glioma-associated antigen MUC 2-63 as CD44.
por: Romeijn, P., et al.
Publicado: (1994)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
por: Perrone, Giuseppe, et al.
Publicado: (2012)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance
por: Wang, Xiaohong, et al.
Publicado: (2020)

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
por: Cao, Xueyuan, et al.
Publicado: (2014)

CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma
por: Gerardo-Ramírez, Monserrat, et al.
Publicado: (2022)

Tumorigenic and Metastatic Role of CD44(−/low)/CD24(−/low) Cells in Luminal Breast Cancer
por: Vikram, Rajeev, et al.
Publicado: (2020)

MiR-205-5p/GGCT Attenuates Growth and Metastasis of Papillary Thyroid Cancer by Regulating CD44
por: Li, Han-Ning, et al.
Publicado: (2022)

Brca1 breast tumors contain distinct CD44(+)/CD24(- )and CD133(+ )cells with cancer stem cell characteristics
por: Wright, Mollie H, et al.
Publicado: (2008)

Characterization of the CD49f(+)/CD44(+)/CD24(−) single-cell derived stem cell population in basal-like DCIS cells
por: Duru, Nadire, et al.
Publicado: (2016)

The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008)

In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147
por: Hao, Jingli, et al.
Publicado: (2012)

Overexpression of CBS/H(2)S inhibits proliferation and metastasis of colon cancer cells through downregulation of CD44
por: Zhang, Yuyang, et al.
Publicado: (2022)

CD117(+)CD44(+) Stem T Cells Develop in the Thymus and Potently Suppress T-cell Proliferation by Modulating the CTLA-4 Pathway
por: Wei, Yang, et al.
Publicado: (2017)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

LRRC4 mediates the formation of circular RNA CD44 to inhibitGBM cell proliferation
por: Feng, Jianbo, et al.
Publicado: (2021)

Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S
por: Kong, Lingwei, et al.
Publicado: (2022)

Radiation resistance in breast cancer: are CD44(+)/CD24(-)/proteosome(low)/PKH26(+ )cells to blame?
por: Nakshatri, Harikrishna
Publicado: (2010)

SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2010)

Relationship of CD44(+)CD24(-/low) breast cancer stem cells and axillary lymph node metastasis
por: Wei, Wei, et al.
Publicado: (2012)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44(+)/CD24(−) breast cancer stem cells
por: Erol, Ayse, et al.
Publicado: (2017)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Utility of CD44/CD24 in the Outcome and Prognosis of Oral Squamous Cell Carcinoma: A Systematic Review
por: Poothakulath Krishnan, Reshma, et al.
Publicado: (2023)

CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model
por: Mayr, Lisa, et al.
Publicado: (2017)

KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas
por: Wang, Dan, et al.
Publicado: (2023)

PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway
por: Sun, Jinmin, et al.
Publicado: (2021)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
por: Yong, Ching-Shya, et al.
Publicado: (2012)

CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms
por: Soave, Danilo Figueiredo, et al.
Publicado: (2013)

CD44 promotes cell proliferation in non-small cell lung cancer
por: Hu, Bo, et al.
Publicado: (2018)

Cep63 knockout inhibits the malignant phenotypes of papillary thyroid cancer cell line TPC-1
por: Liu, Chenguang, et al.
Publicado: (2021)

Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
por: Fillmore, Christine, et al.
Publicado: (2007)

Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
por: Sahlberg, Sara Häggblad, et al.
Publicado: (2014)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pdls9l3msq44gquh0uffo87f7h